NSEReply to Clarification- Financial results10 Jul 2026 · 10 Jul 2026, 04:14 pm

Reply to Clarification- Financial results

Gujarat Kidney And Super Speciality Limited · GKSL

✦ AI SummaryResults

Gujarat Kidney And Super Speciality Limited has clarified a deficiency observation in its financial results for the quarter ended 31-Mar-2026, stating that the date mentioned for signing of the standalone financial statements was incorrect due to a typographical error. The company has undertaken to publish the corrected financial statements on its website and assured the exchange of its continued compliance with SEBI LODR Regulations.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

The Exchange had sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.

Attachments (1)

📄

GKSL2025_27062026180528_Final_Corrected_Financial.pdf

pdf

Download →
View document text
Date: 26/06/2026 National Stock Exchange of India Limited Listing Department “Exchange Plaza,” C-1, Block – G, Bandra – Kurla Complex, Bandra (E), Mumbai 400 051 Sub: Reply to your email dated 25/06/2026 seeking Clarification for Financial results - Deficiency Observation – Financial Results submitted on 28-May-2026 We refer to the above-mentioned communication wherein it has been observed that the date mentioned for signing of the Standalone Financial Statements (SFS) is incorrect and not in conformity with the format prescribed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, we wish to submit the following clarification: 1. Nature of Error: The incorrect date mentioned in the Standalone Financial Statements is purely a typographical/clerical error. The actual date of signing of the Standalone Financial Statements by the authorised signatories was 28-May-2025. 2. Corrective Action: We hereby undertake to publish the corrected Standalone Financial Statements with the accurate signing date on the website of Gujarat Kidney and Super Speciality Limited at www.gujaratsuperspecialityhospital.com. The corrected document shall be uploaded at the earliest. 3. Undertaking: We confirm that this error was inadvertent and has no bearing on the financial figures, disclosures, or substance of the financial results. Appropriate internal checks shall be put in place to avoid recurrence of such typographical errors in future submissions. We regret the inconvenience caused due to this inadvertent error and assure the Exchange of our continued compliance with the applicable SEBI LODR Regulations. We are enclosing the corrected copy of the Standalone Financial Statements. Thanking you, Yours faithfully, For Gujarat Kidney and Super Speciality Limited Dr Pragnesh Bharpoda Managing Director DIN:01033141